Cancer
"It's important to have all the tools in our toolbox so we can continue offering patients the best care."
The pace of radiopharmaceutical development is accelerating.
Artificial intelligence is giving medical professionals a new edge.
Grandmother’s lessons inspire Native American oncologist.
Dr. Willman mobilizes others toward a common goal through her efforts to revolutionize cancer care.
In theranostics, one area of great interest is the development of alpha-emitting radioisotopes because of their power in targeting and killing cancer cells. But what[...]
Mayo Clinic is designing the next generation of radiopharmaceutical therapies.
A groundbreaking approach called theranostics is emerging as a powerful tool in the fight against cancer.
Michael Story, Ph.D., and his team of top investigators are paving the way in carbon ion therapy research.
Sungjune Kim, M.D., Ph.D., is focused on the clinical evidence for carbon ion therapy.
Discover how researchers are pursuing answers for patients with unmet needs.
Chris Beltran, Ph.D., is building carbon ion therapies with the patient in mind.
How does this innovative therapy work, and how does it stack up against other cancer radiation therapies?